Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Michael Williams | Jan 15, 2026 at 9:28 AM EST

$1.5 Million at 60 Looks Solid Until You Calculate Five Years Without Medicare

Retiring at 60 with $1.5 million sounds comfortable until you realize Medicare doesn’t begin until 65. That five-year gap creates…

Michael Williams | Jan 12, 2026 at 1:01 PM EST

What $6,500 a Month Really Looks Like in Retirement at 67

Retiring at 67 with $6,500 in monthly income places you solidly in middle-class territory, but the financial reality behind that…

David Beren | Jan 12, 2026 at 12:49 PM EST

How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?

At 60 years old with $2 million saved, you can safely say that you are in a good position that…

William Temple | Jan 10, 2026 at 8:59 AM EST

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but…

Lee Jackson | Jan 5, 2026 at 9:12 AM EST

5 Best Passive Income Dividend Kings With Yields Up to 7% to Buy in 2026

These five top Dividend Kings with yields up to 7% looked poised to deliver strong total return and passive income…

Douglas A. McIntyre | Dec 23, 2025 at 9:15 AM EST

Companies Most Likely to Raise Dividends in 2026

These four companies have increased their dividends annually for decades. And they will mostly likely boost their payouts again in…

David Beren | Dec 20, 2025 at 10:31 AM EST

What Retirement Really Looks Like With $2.5 Million in Savings

For as long as most of us can remember, the idea of retiring with $2.5 million in the “bank,” is…

Jeremy Phillips | Dec 18, 2025 at 7:19 AM EST

5 Dividends That Beat Social Security’s Unpredictable COLA Adjustments

Social Security’s cost-of-living adjustments swing wildly year to year. The 2025 COLA came in at 2.5%, down from 3.2% in…

Trey Thoelcke | Dec 17, 2025 at 8:45 AM EST

Share Offerings Prompt Huge Insider Buying in These 3 Biotechs

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.

William Temple | Dec 15, 2025 at 6:42 AM EST

The Best Dividend Stocks for Retirement Portfolios in 2026

Retirement portfolios need growing income that outpaces inflation and safety that lets you sleep at night. The best retirement dividend…

Jeremy Phillips | Dec 14, 2025 at 9:51 AM EST

Forget the 2.8% Social Security Increase. These Aristocrats Pay You 4% to 7% More Annually

The Social Security Administration announced in October that beneficiaries will receive a 2.8% cost-of-living adjustment (COLA) in 2026, following a…

William Temple | Dec 13, 2025 at 12:26 PM EST

5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine

Building wealth through dividends requires more than chasing high yields. The path to “getting rich” combines meaningful current income with…

William Temple | Dec 12, 2025 at 7:22 AM EST

Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks

Dividend investing rewards patience. The best dividend stocks don’t just pay consistently—they raise payouts year after year, compounding income for…

William Temple | Dec 10, 2025 at 5:28 PM EST

5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now

For investors approaching or in retirement, the right stock portfolio balances reliable income, low volatility, and consistent dividend growth. Among…

Lee Jackson | Dec 9, 2025 at 9:18 AM EST

The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026

Given the potential for a sizable sell-off, it makes sense for investors to move to S&P 500 Dividend Aristocrat stocks…

1 … 3 4 5 6 7 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

$1.5 Million at 60 Looks Solid Until You Calculate Five Years Without Medicare

What $6,500 a Month Really Looks Like in Retirement at 67

How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

5 Best Passive Income Dividend Kings With Yields Up to 7% to Buy in 2026

Companies Most Likely to Raise Dividends in 2026

What Retirement Really Looks Like With $2.5 Million in Savings

5 Dividends That Beat Social Security’s Unpredictable COLA Adjustments

Share Offerings Prompt Huge Insider Buying in These 3 Biotechs

The Best Dividend Stocks for Retirement Portfolios in 2026

Forget the 2.8% Social Security Increase. These Aristocrats Pay You 4% to 7% More Annually

5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine

Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks

5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now

The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

$1.5 Million at 60 Looks Solid Until You Calculate Five Years Without Medicare

What $6,500 a Month Really Looks Like in Retirement at 67

How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

5 Best Passive Income Dividend Kings With Yields Up to 7% to Buy in 2026

Companies Most Likely to Raise Dividends in 2026

What Retirement Really Looks Like With $2.5 Million in Savings

5 Dividends That Beat Social Security’s Unpredictable COLA Adjustments

Share Offerings Prompt Huge Insider Buying in These 3 Biotechs

The Best Dividend Stocks for Retirement Portfolios in 2026

Forget the 2.8% Social Security Increase. These Aristocrats Pay You 4% to 7% More Annually

5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine

Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks

5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now

The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s